Levonorgestrel . Suppliers & Bulk Manufacturers

Available Forms: Tablet and IUD

Available Strengths: Tablet: 1.5 mg; IUD- 52 mg,19.5 mg

Reference Brands: Plan B One-Step®(US), NorLevo®(EU), Mirena®, Kyleena®(EU & US)

Category: Women's Health

Levonorgestrel is a widely used contraceptive progestin available as emergency contraceptive tablets (1.5 mg) and long-acting intrauterine devices (up to 52 mg). Top brands like Plan B One-Step®, NorLevo®, and Mirena® lead the US and EU markets. Trusted by healthcare providers and pharmacies, levonorgestrel supports effective pregnancy prevention and family planning. Its proven efficacy and multiple formulations make it a must-have product for pharmaceutical distributors and women’s health suppliers. Levonorgestrel . is available in Tablet and IUD and strengths such as Tablet: 1.5 mg; IUD- 52 mg,19.5 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Levonorgestrel . is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Levonorgestrel . can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Levonorgestrel is a key medication in women’s health, used for emergency contraception and long-term birth control through oral tablets and intrauterine devices (IUDs). Leading brands such as Plan B One-Step®, NorLevo®, and Mirena® dominate the US and EU markets. Available in strengths ranging from 1.5 mg single-dose tablets to 52 mg IUDs, levonorgestrel offers versatile contraceptive options. Pharmaceutical distributors, hospitals, and clinics rely on this proven progestin for effective pregnancy prevention and family planning solutions. Its widespread acceptance and regulatory approvals make levonorgestrel an essential product in women’s healthcare portfolios.